Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0614620120590060437
Korean Journal of Gastroenterology
2012 Volume.59 No. 6 p.437 ~ p.440
Successful Primary Infliximab Treatment of Orofacial Crohn¡¯s Disease without Gastrointestinal Manifestation
Jung Bo-Yong

Lee Suck-Ho
Chung Seung-Kyu
Lee Chang-Kyun
Lee Tae-Hoon
Chung Il-Kwun
Kim Sun-Joo
Cho Hyun-Deuk
Abstract
Crohn¡¯s disease is a chronic inflammatory bowel disease that can involve the whole gastrointestinal tract. The orofacial manifestation of Crohn¡¯s disease, which is rare, can develop irrespective of intestinal involvement. These orofacial lesions are often misdiagnosed as simple oral ulcers. Corticosteroids are the mainstay of therapy for orofacial Crohn¡¯s disease. However, infliximab, the chimeric monoclonal antibody to tumor necrosis factor-a, is now considered as a primary treatment because of the disease¡¯s relatively high rate of steroid resistance.¡¡We present a case of deep oral ulcer and periorbital swelling in a 65-year-old woman. She was diagnosed with intestinal Crohn¡¯s disease 7 years ago, which was in remission after treatment with an immunosuppressive agent (azathioprine). The patient was given the diagnosed with orofacial Crohn¡¯s disease and successfully treated with infliximab. (Korean J Gastroenterol 2012;59:437-440)
KEYWORD
Orofacial Crohn¡¯s disease, Oral ulcer, infliximab
FullTexts / Linksout information
 
Listed journal information
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø